A MOUSE MODEL REVEALS VULNERABILITY OF IDH1-MUTATED GLIOMA TO FERROPTOSIS

被引：0

作者：

Mela, Angeliki ^{[1
]}

Dovas, Athanassios ^{[1
]}

Mahajan, Aayushi ^{[1
]}

Humala, Nelson ^{[1
]}

Trang Nguyen ^{[1
]}

Kanangat, Smriti ^{[1
]}

Upadhyayula, Pavan ^{[1
]}

Sprinzen, Lisa ^{[2
]}

Argenziano, Michael ^{[1
]}

Huang, Dennis ^{[3
]}

Guo, Jia ^{[4
]}

Casaccia, Patrizia ^{[3
]}

Siegelin, Markus ^{[1
]}

Stockwell, Brent ^{[4
]}

Bruce, Jeffrey ^{[1
]}

Canoll, Peter ^{[5
]}

机构：

[1] Columbia Univ, Med Ctr, New York, NY USA

[2] Univ Calif San Francisco, San Francisco, CA USA

[3] CUNY, ASRC, New York, NY USA

[4] Columbia Univ, New York, NY USA

[5] Columbia Univ, Irving Med Ctr, New York, NY USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EXTH-20

引用

页数：2

共 50 条

[21] Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
Molenaar, Remco J.
Botman, Dennis
Smits, Myrthe A.
Hira, Vashendriya V.
van Lith, Sanne A.
Stap, Jan
Henneman, Peter
Khurshed, Mohammed
Lenting, Krissie
Mul, Adri N.
Dimitrakopoulou, Dionysia
van Drunen, Cornelis M.
Hoebe, Ron A.
Radivoyevitch, Tomas
Wilmink, Johanna W.
Maciejewski, Jaroslaw P.
Vandertop, W. Peter
Leenders, William P.
Bleeker, Fonnet E.
van Noorden, Cornelis J.
CANCER RESEARCH, 2015, 75 (22) : 4790 - 4802
[22] MODELING IDH1-MUTATED GLIOMAS: GENERATION, CHARACTERIZATION AND THERAPEUTIC SENSITIVITIES OF SEVEN PATIENT-DERIVED IDH1-MUTANT GLIOMA CELL LINES
Verheul, Cassandra
Kers, Trisha
Van der Kaaij, Marielle
Pierson, Tessa
Gao, Ya
Dirven, Clemens
Struys, Eduard
Salomons, Gajja
Leenstra, Sieger
French, Pim
Lamfers, Martine
NEURO-ONCOLOGY, 2018, 20 : 274 - 274
[23] Two rare cases of IDH1-mutated gliosarcomas arising in IDH1-mutated, 1p/19q non-codeleted diffuse gliomas with prominent oligodendroglial morphology
Soukup, J.
Bartos, M.
Hobza, V.
Kasparova, P.
Kohout, A.
Cesak, T.
VIRCHOWS ARCHIV, 2020, 477 : S111 - S111
[24] IDH1-MUTATED PITUITARY ADENOMA CHALLENGES TRADITIONAL CHARACTERIZATION OF MAFFUCCI SYNDROME
Hong, Christopher
Hao, Shuyu
Feng, Jie
Yang, Chunzhang
Chittiboina, Prashant
Zhang, Junting
Zhuang, Zhengping
NEURO-ONCOLOGY, 2015, 17 : 7 - 7
[25] IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis
Gao, Ya
de Wit, Maurice
Struys, Eduard A.
van der Linde, Herma C. Z.
Salomons, Gajja S.
Lamfers, Martine L. M.
Willemsen, Rob
Smite, Peter A. E. Sillevis
French, Pim J.
PLOS ONE, 2018, 13 (06):
[26] Targeting Nrf2 driven glutathione de novo synthesis as a novel strategy to suppresses IDH1-mutated glioma
Liu, Yang
Yu, Di
Cai, Sabrina
Yang, Chunzhang
CANCER RESEARCH, 2019, 79 (13)
[27] IDH1-mutated relapsed or refractory AML: current challenges and future prospects
Eduardo Megias-Vericat, Juan
Ballesta-Lopez, Octavio
Barragan, Eva
Montesinos, Pau
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019, 9 : 19 - 32
[28] IMPAIRED PARP1 DNA REPAIR DEFINES CHEMOSENSITIVITY IN IDH1-MUTATED CELL
Lu, Yanxin
Liu, Yang
Gilbert, Mark
Wu, Jing
Yang, Chunzhang
NEURO-ONCOLOGY, 2018, 20 : 102 - 102
[29] Teaching NeuroImage: Histopathologically Confirmed Intracranial Enchondroma/Low-Grade Chondrosarcoma and IDH1-Mutated Diffuse Glioma in Ollier Disease
Gregory, Timothy A.
Taylor, Lynne P.
NEUROLOGY, 2021, 97 (17) : E1747 - E1748
[30] CHARACTERISTICS OF THE TUMOR MICROENVIRONMENT IN IDH1-MUTATED CHOLANGIOCARCINOMA PATIENTS FROM CLARIDHY TRIAL
Saatcioglu, H. Duygu
Valle, Juan
Macarulla, Teresa
Javle, Milind
Oh, Do-Youn
Goyal, Lipika
Conway, Jake
Iyer, Janani
Najdawi, Fedaa
Shah, Chintan
Gliser, Camelia
Pandya, Susan
Daigle, Scott
Abou-Alfa, Ghassan
Kelley, Robin
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A576 - A577

← 1 2 3 4 5 →